$201 Million is the total value of Finepoint Capital LP's 30 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $18,890,712 | +22.7% | 331,416 | +9.7% | 9.41% | +76.6% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $18,106,544 | +8.7% | 1,489,025 | +12.3% | 9.02% | +56.5% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $17,620,176 | +22.6% | 145,357 | +15.9% | 8.78% | +76.6% |
| PRTA | Buy | PROTHENA CORP PLC | $16,853,725 | -22.2% | 349,300 | +10.1% | 8.39% | +12.0% |
| GLPG | Buy | GALAPAGOS NVspon adr | $15,846,668 | -4.2% | 458,659 | +12.7% | 7.89% | +37.9% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $15,335,610 | +22.9% | 163,772 | +17.2% | 7.64% | +76.9% |
| CYTK | Buy | CYTOKINETICS INC | $12,717,676 | +5.6% | 431,693 | +17.0% | 6.33% | +52.1% |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $12,297,821 | -21.5% | 563,345 | +14.4% | 6.12% | +13.1% |
| RVMD | New | REVOLUTION MEDICINES INC | $11,819,360 | – | 427,000 | +100.0% | 5.89% | – |
| ARVN | Buy | ARVINAS INC | $9,912,308 | -2.9% | 504,700 | +22.6% | 4.94% | +39.7% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $8,008,640 | -31.6% | 895,821 | +17.6% | 3.99% | -1.5% |
| MORF | Buy | MORPHIC HOLDING INC | $7,453,906 | -54.8% | 325,356 | +13.1% | 3.71% | -34.9% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $7,324,017 | -16.9% | 870,870 | +24.1% | 3.65% | +19.7% |
| New | CALIDI BIOTHERAPEUTICS INC | $415,625 | – | 125,000 | +100.0% | 0.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| YPF SOCIEDAD ANONIMA | 17 | Q4 2018 | 32.7% |
| IRSA INVERSIONES Y REP S A | 15 | Q2 2018 | 10.1% |
| CHENIERE ENERGY INC | 14 | Q1 2018 | 29.9% |
| ALLY FINL INC | 13 | Q4 2017 | 42.0% |
| CRESUD S A C I F Y A | 13 | Q4 2017 | 4.0% |
| BRIDGETOWN HOLDINGS LTD | 9 | Q3 2023 | 0.2% |
| ARES ACQUISITION CORP | 9 | Q3 2023 | 0.2% |
| CHURCHILL CAPITAL CORP V | 9 | Q3 2023 | 0.2% |
| CHURCHILL CAPITAL CORP VII | 9 | Q3 2023 | 0.1% |
| CHURCHILL CAPITAL CORP VI | 9 | Q3 2023 | 0.1% |
View Finepoint Capital LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View Finepoint Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.